| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4935088 | Schizophrenia Research | 2016 | 6 Pages |
Abstract
These preliminary findings suggest that varenicline may produce differential effects in non-smoking schizophrenia compared to control subjects. Given the role of LTP in learning and memory, these observations may suggest the potential for varenicline in the treatment of cognitive deficits in patients with schizophrenia.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Alanna C. Bridgman, Mera S. Barr, Michelle S. Goodman, Reza Zomorrodi, Tarek Rajji, Bernard Le Foll, Robert Chen, Zafiris J. Daskalakis, Tony P. George,